Your browser doesn't support javascript.
loading
Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung.
Schultz, H; Marwitz, S; Baron-Lühr, B; Zissel, G; Kugler, C; Rabe, K F; Zabel, P; Vollmer, E; Gerdes, J; Goldmann, T.
Affiliation
  • Schultz H; Clinical and Experimental Pathology, Research Center Borstel, Parkallee 1-40, D-23845 Borstel, Germany.
Br J Cancer ; 105(5): 673-81, 2011 Aug 23.
Article in En | MEDLINE | ID: mdl-21811254

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Biomarkers, Tumor / Lung Neoplasms / Antibodies, Monoclonal Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies / Screening_studies Limits: Animals / Female / Humans Language: En Journal: Br J Cancer Year: 2011 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Biomarkers, Tumor / Lung Neoplasms / Antibodies, Monoclonal Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies / Screening_studies Limits: Animals / Female / Humans Language: En Journal: Br J Cancer Year: 2011 Document type: Article Affiliation country: Germany Country of publication: United kingdom